Literature DB >> 22322890

Overexpression of sigma-1 receptor inhibits ADAM10 and ADAM17 mediated shedding in vitro.

Juan Li1, Bin Liu, Xiaofei Gao, Zhixing Ma, Tianyi CaoSong, Yan-ai Mei, Yufang Zheng.   

Abstract

The sigma-1 receptor is a molecular chaperone protein highly enriched in the brain. Recent studies linked it to many diseases, such as drug addition, Alzheimer's disease, stroke, depression, and even cancer. Sigma-1 receptor is enriched in lipid rafts, which are membrane microdomains essential in signaling processes. One of those signaling processes is ADAM17- and ADAM10-dependent ectodomain shedding. By using an alkaline phosphatase tagged substrate reporter system, we have shown that ADAM10-dependent BTC shedding was very sensitive to both membrane lipid component change and sigma-1 receptor agonist DHEAS treatment while ADAM17-dependent HB-EGF shedding was not; and overexpression of sigma-1 receptor diminished ADAM17- and ADAM10-dependent shedding. Our results indicate that sigma-1 receptor plays an important role in modifying the function of transmembrane proteases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22322890      PMCID: PMC4875409          DOI: 10.1007/s13238-012-2006-9

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  38 in total

Review 1.  Neuro(active)steroids actions at the neuromodulatory sigma1 (sigma1) receptor: biochemical and physiological evidences, consequences in neuroprotection.

Authors:  Tangui Maurice; Catherine Grégoire; Julie Espallergues
Journal:  Pharmacol Biochem Behav       Date:  2006-09-01       Impact factor: 3.533

2.  Cocaine binding at sigma receptors.

Authors:  J Sharkey; K A Glen; S Wolfe; M J Kuhar
Journal:  Eur J Pharmacol       Date:  1988-04-27       Impact factor: 4.432

3.  ErbB-4 and TNF-alpha converting enzyme localization to membrane microdomains.

Authors:  Kristina W Thiel; Graham Carpenter
Journal:  Biochem Biophys Res Commun       Date:  2006-09-28       Impact factor: 3.575

4.  Repeated methamphetamine-treatment alters brain sigma receptors.

Authors:  Y Itzhak
Journal:  Eur J Pharmacol       Date:  1993-01-12       Impact factor: 4.432

5.  Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin II.

Authors:  Akira Takaguri; Heigoro Shirai; Keita Kimura; Akinari Hinoki; Kunie Eguchi; MaryEllen Carlile-Klusacek; Baohua Yang; Victor Rizzo; Satoru Eguchi
Journal:  J Mol Cell Cardiol       Date:  2010-12-21       Impact factor: 5.000

6.  Statins and the squalene synthase inhibitor zaragozic acid stimulate the non-amyloidogenic pathway of amyloid-beta protein precursor processing by suppression of cholesterol synthesis.

Authors:  Elzbieta Kojro; Petra Füger; Claudia Prinzen; Anna Maria Kanarek; Dorothea Rat; Kristina Endres; Falk Fahrenholz; Rolf Postina
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 7.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

8.  Sigma-1 receptors potentiate epidermal growth factor signaling towards neuritogenesis in PC12 cells: potential relation to lipid raft reconstitution.

Authors:  Minoru Takebayashi; Teruo Hayashi; Tsung-Ping Su
Journal:  Synapse       Date:  2004-08       Impact factor: 2.562

9.  Neuroactive steroid dehydroepiandrosterone sulfate inhibits 5-hydroxytryptamine (5-HT)-evoked glutamate release via activation of sigma-1 receptors and then inhibition of 5-HT3 receptors in rat prelimbic cortex.

Authors:  Lianyan Dong; Yan Zhu; Yi Dong; Jinhui Yang; Yanyan Zhao; Yingjie Qi; Peiying Wu; Yanhua Zhu; Ping Zheng
Journal:  J Pharmacol Exp Ther       Date:  2009-05-06       Impact factor: 4.030

10.  Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.

Authors:  B J Vilner; C S John; W D Bowen
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

View more
  3 in total

1.  Incomplete Differentiation of Engrafted Bone Marrow Endothelial Progenitor Cells Initiates Hepatic Fibrosis in the Rat.

Authors:  Ana C Maretti-Mira; Xiangdong Wang; Lei Wang; Laurie D DeLeve
Journal:  Hepatology       Date:  2019-02-07       Impact factor: 17.425

Review 2.  Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms.

Authors:  Kristina Endres; Thomas Deller
Journal:  Front Mol Neurosci       Date:  2017-03-17       Impact factor: 5.639

3.  In vitro screening of major neurotransmitter systems possibly involved in the mechanism of action of antibodies to S100 protein in released-active form.

Authors:  Evgeniy A Gorbunov; Irina A Ertuzun; Evgeniya V Kachaeva; Sergey A Tarasov; Oleg I Epstein
Journal:  Neuropsychiatr Dis Treat       Date:  2015-11-03       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.